Table 1 Bulbar urethroplasty techniques used in transected group (I), and non-Transected group (II)
The group | The procedure (n = 245) | Number of Cases | Urethroplasty success, n (%) |
|---|---|---|---|
Group I (n = 74 cases) | EPA | 36 (14.69%) | 32 (88.9%) |
Augmented anastomotic urethroplasty | 14 (5.71%) | 12 (85.7%) | |
Dorsal BMG and ventral penile skin flap urethroplasty | 6 (2.45%) | 4 (66.7%) | |
Staged urethroplasty | 18 (7.35%) | 16 (88.9%) | |
Group II (n = 171) | Dorsal onlay BMG urethroplasty | 103 (42.04%) | 91 (88.3%) |
Ventral onlay BMG urethroplasty | 62 (25.31%) | 54 (87.1%) | |
Double face BMG urethroplasty | 2 (0.82%) | 1 (50%) | |
Dorsal inlay BMG urethroplasty (Asopa) | 3 (1.23%) | 2 (66.7%) | |
Non-transecting anastomotic bulbar urethroplasty | 1 (0.4) | 1 (100%) |